Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

NCT01189266 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

79

Enrollment

NIH

Sponsor class

Conditions

Anaplastic Astrocytoma
Anaplastic Oligoastrocytoma
Diffuse Intrinsic Pontine Glioma
Gliosarcoma

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
RADIATION: Intensity-Modulated Radiation Therapy
OTHER: Laboratory Biomarker Analysis
DRUG: Vorinostat

Sponsor

National Cancer Institute (NCI)